Earnings History Data for Xenon Pharmaceuticals Inc. (XENE) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan as well as more prevalent diseases. The company offers Glybera (R), a gene therapy for the treatment of lipoprotein lipase deficiency, an orphan disorder. Xenon Pharmaceuticals Inc. is headquartered in Burnaby, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | AH | XENE | Xenon Pharmaceuticals Inc. | 3,410 | -0.81 | -0.82 | -0.73 | Xenon Pharma GAAP EPS of -$0.81 in-line [11/12/2024 4:15 PM] |
41.92 | -1.47 (-3.38%) |
43.39 | 0.0 (0.00%) |
27.99 - 50.99 | 402,211 | 340,000 | 51,994 | ||
|
||||||||||||||||||
| 08-08-2024 | AH | XENE | Xenon Pharmaceuticals Inc. | 3,170 | -0.75 | -0.72 | -0.72 | Xenon Pharma GAAP EPS of -$0.75 misses by $0.04 [8/8/2024 4:11 PM] |
39.66 | -1.34 (-3.28%) |
41.01 | 0.0 (0.00%) |
27.99 - 50.99 | 360,981 | 360,000 | 6,569 | ||
| 09-05-2024 | AH | XENE | Xenon Pharmaceuticals Inc. | 3,280 | -0.62 | -0.69 | -0.63 | Xenon Pharma GAAP EPS of -$0.62 beats by $0.05 [5/9/2024 4:41 PM] |
40.48 | -2.01 (-4.72%) |
40.88 | -1.61 (-3.79%) |
27.99 - 50.99 | 468,847 | 310,000 | 498 | ||
| 29-02-2024 | AH | XENE | Xenon Pharmaceuticals Inc. | 3,210 | -0.64 | -0.77 | -0.57 | Xenon Pharma GAAP EPS of -$0.64 beats by $0.12 [2/29/2024 4:05 PM] |
46.76 | -0.45 (-0.94%) |
47.20 | 0.0 (0.00%) |
27.99 - 50.99 | 650,574 | 430,000 | 43,427 | ||
| 08-11-2023 | AH | XENE | Xenon Pharmaceuticals Inc. | 2,110 | -0.73 | -0.75 | -0.57 | Xenon Pharma GAAP EPS of -$0.73 beats by $0.04 [11/8/2023 4:28 PM] |
30.07 | -2.08 (-6.47%) |
32.15 | 0.0 (0.00%) |
29.67 - 43.75 | 1,954,005 | 580,000 | 41,018 | ||
| 09-08-2023 | AH | XENE | Xenon Pharmaceuticals Inc. | 2,260 | -0.72 | -0.69 | -0.55 | Xenon Pharma GAAP EPS of -$0.72 misses by $0.01 [8/9/2023 4:03 PM] |
38.44 | 2.99 (8.43%) |
35.45 | 0.0 (0.00%) |
31.79 - 43.75 | 825,933 | 340,000 | 3,747 | ||
| 09-05-2023 | AH | 4:00 PM ET (May 9) |
XENE | Xenon Pharmaceuticals Inc. | 2,670 | -0.63 | -0.62 | -0.35 | Xenon Pharma GAAP EPS of -$0.63 beats by $0.01 [5/9/2023 4:47 PM] |
41.19 | -2.35 (-5.41%) |
43.54 | 0.0 (0.00%) |
25.08 - 43.57 | 750,115 | 410,000 | 5,473 | |
| 01-03-2023 | AH | 4:00 PM ET (Mar 1) |
XENE | Xenon Pharmaceuticals Inc. | 2,320 | -0.57 | -0.58 | -0.57 | Xenon Pharma GAAP EPS of -$0.57 beats by $0.02 [3/1/2023 4:03 PM] |
37.38 | -2.97 (-7.36%) |
40.35 | 0.0 (0.00%) |
24.94 - 41.39 | 1,273,800 | 350,000 | 8,406 | |
| 08-11-2022 | AH | 4:00 PM ET (Nov 8) |
XENE | Xenon Pharmaceuticals Inc. | 2,280 | -0.57 | -0.52 | -0.36 | Xenon Pharma GAAP EPS of -$0.57 misses by $0.05, revenue of $0.13M misses by $2.89M [11/8/2022 4:08 PM] |
33.18 | -2.22 (-6.27%) |
35.40 | 0.0 (0.00%) |
23.26 - 41.39 | 859,914 | 370,000 | 8,022 | |
| 09-08-2022 | AH | 4:30 PM ET (Aug 9) |
XENE | Xenon Pharmaceuticals Inc. | 2,020 | -0.55 | -0.49 | -0.51 | Xenon Pharma GAAP EPS of -$0.55 misses by $0.06, revenue of $0.54M misses by $2.71M [8/9/2022 5:02 PM] |
39.80 | 0.45 (1.14%) |
40.00 | 0.65 (1.65%) |
14.65 - 40.92 | 524,051 | 470,000 | 7,016 | |
|
||||||||||||||||||
| 10-05-2022 | AH | 4:00 PM ET (May 10) |
XENE | Xenon Pharmaceuticals Inc. | 1,450 | -0.35 | -0.38 | -0.42 | Xenon Pharma GAAP EPS of -$0.35 beats by $0.07, revenue of $8.77M beats by $1.03M [5/10/2022 4:13 PM] |
26.93 | -1.64 (-5.74%) |
28.57 | 0.0 (0.00%) |
14.65 - 36.42 | 589,805 | 590,000 | 12,687 | |
|
||||||||||||||||||
| 01-03-2022 | AH | 4:00 PM ET (Mar 1) |
XENE | Xenon Pharmaceuticals Inc. | 1,600 | -0.57 | -0.47 | -0.34 | Xenon Pharma GAAP EPS of -$1.77 misses by $1.41, revenue of $18.43M beats by $12.13M [3/1/2022 4:06 PM] |
32.77 | 1.01 (3.18%) |
31.76 | 0.0 (0.00%) |
14.65 - 36.42 | 443,022 | 400,000 | 2,425 | |
| 10-11-2021 | AH | 4:00 PM ET (Nov 10) |
XENE | Xenon Pharmaceuticals Inc. | 1,820 | -0.36 | -0.44 | -0.25 | Xenon Pharma EPS beats by $0.01, misses on revenue [11/10/2021 4:03 PM] |
31.47 | -2.32 (-6.87%) |
33.79 | 0.0 (0.00%) |
9.99 - 36.42 | 793,078 | 550,000 | 5,230 | |
| 11-08-2021 | AH | 4:00 PM ET (Aug 11) |
XENE | Xenon Pharmaceuticals Inc. | 675.96 | -0.51 | -0.49 | 0.00 | Xenon Pharma EPS misses by $0.03, misses on revenue [8/11/2021 4:05 PM] |
17.94 | -0.74 (-3.96%) |
18.60 | -0.08 (-0.43%) |
9.32 - 21.94 | 210,113 | 210,000 | 656 | |
|
||||||||||||||||||
| 11-05-2021 | AH | 4:00 PM ET (May 11) |
XENE | Xenon Pharmaceuticals Inc. | 758.22 | -0.42 | -0.45 | -0.22 | Xenon Pharma EPS beats by $0.01, beats on revenue [5/11/2021 4:13 PM] |
17.46 | -0.47 (-2.62%) |
18.35 | 0.19 (1.05%) |
9.32 - 21.94 | 107,883 | 100,000 | 1 | |
| 01-03-2021 | AH | XENE | Xenon Pharmaceuticals Inc. | 523.01 | -0.34 | -0.40 | -0.42 | Xenon Pharma EPS beats by $0.06, beats on revenue [3/1/2021 4:21 PM] |
20.12 | 2.20 (12.30%) |
17.92 | 0.0 (0.00%) |
7.00 - 21.87 | 439,834 | 212,914 | 1,754 | ||
| 05-11-2020 | AH | 4:00 PM ET (Nov 5) |
XENE | Xenon Pharmaceuticals Inc. | 384.24 | -0.25 | -0.15 | -0.33 | Xenon Pharma EPS misses by $0.14, misses on revenue [11/5/2020 5:01 PM] |
10.98 | -0.88 (-7.38%) |
11.50 | 0.27 (2.40%) |
7.00 - 18.45 | 286,213 | 140,530 | 561 | |
|
|
||||||||||||||||||
| 06-08-2020 | AH | 4:00 PM ET (Aug 6) |
XENE | Xenon Pharmaceuticals Inc. | 402.90 | N/A | -0.24 | -0.37 | Xenon Pharma EPS beats by $0.24, beats on revenue [8/6/2020 4:11 PM] |
11.08 | -0.22 (-1.95%) |
11.30 | 0.0 (0.00%) |
7.00 - 18.45 | 119,944 | 107,166 | 2,967 | |
|
|
||||||||||||||||||
| 21-05-2020 | AH | 4:00 PM ET (May 21) |
XENE | Xenon Pharmaceuticals Inc. | 500.92 | -0.22 | -0.31 | -0.42 | Xenon Pharma EPS beats by $0.10, beats on revenue [5/21/2020 4:03 PM] |
15.24 | 1.37 (9.88%) |
0.0 | 0.0 (0.00%) |
7.00 - 18.45 | 342,090 | 118,066 | 0 | |
|
|
||||||||||||||||||